BALAXI PHARMACEUTICALS LIMITED — Others, 09-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Balaxi Pharmaceuticals Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended March 31, 2025. Alongside this, the company has received a compliance certificate from Aarthi Consultants, its Registrar and Share Transfer Agent, affirming adherence to the dematerialization process as per required regulations. This update indicates a commitment to operational transparency and proper governance, which may bolster investor confidence. Given the emphasis on compliance and financial updates, the outlook remains positive for stakeholders, reflecting a solid operational foundation amid ongoing strategic initiatives.